Literature DB >> 23480279

Experimental and computational study of the interaction of novel colchicinoids with a recombinant human αI/βI-tubulin heterodimer.

Jonathan Y Mane1, Valentyna Semenchenko, Rolando Perez-Pineiro, Philip Winter, David Wishart, Jack A Tuszynski.   

Abstract

The binding free energies on human tubulin of selected colchicine and thiocolchicine compounds were determined. Two methods were used for the determination of binding free energies: one is based on theoretical prediction simulating the dissociation of the compound from tubulin using a series of molecular dynamics simulations, and the other method involves a series of experiments that measured the affinity of the compound on a synthetically expressed and purified tubulin protein using a spectrofluorometric technique.
© 2013 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23480279     DOI: 10.1111/cbdd.12132

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  3 in total

1.  Screening Anti-Cancer Drugs against Tubulin using Catch-and-Release Electrospray Ionization Mass Spectrometry.

Authors:  Reza Rezaei Darestani; Philip Winter; Elena N Kitova; Jack A Tuszynski; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2016-03-04       Impact factor: 3.109

2.  Designing and Testing of Novel Taxanes to Probe the Highly Complex Mechanisms by Which Taxanes Bind to Microtubules and Cause Cytotoxicity to Cancer Cells.

Authors:  Marc St George; Ahmed T Ayoub; Asok Banerjee; Cassandra D M Churchill; Philip Winter; Mariusz Klobukowski; Carol E Cass; Richard F Ludueña; Jack A Tuszynski; Sambasivarao Damaraju
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

3.  A new antiproliferative noscapine analogue: chemical synthesis and biological evaluation.

Authors:  Peter E Ghaly; Rabab M Abou El-Magd; Cassandra D M Churchill; Jack A Tuszynski; F G West
Journal:  Oncotarget       Date:  2016-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.